Clearance Summary
Tria Firm Ureteral Stent received FDA 510(k) clearance under submission number K190603, sponsored by Boston Scientific Corporation. The device was reviewed via the Special premarket notification pathway and assigned to the Gastroenterology, Urology review panel. The statutory decision date of record is 2019-05-24.
- Submission: K190603
- Applicant / Sponsor: Boston Scientific Corporation
- Clearance pathway: Special
- Review panel: Gastroenterology, Urology
- Device class: Class II
- Regulation citation: 21 CFR 876.4620
- Decision date: 2019-05-24
Classification & Regulation
This clearance is catalogued under FDA product code FAD and 21 CFR 876.4620, within the Gastroenterology, Urology review panel as a Class II device.